Provectus Biopharmaceuticals Inc (PVCT) stock news · rev $336.1K
Provectus Biopharmaceuticals Inc (PVCT) is a biotechnology company listed on OTCQB.
This PVCT news page leads with what Provectus Biopharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for PVCT yet. We will not pad this page with generic market recap.
Latest reported PVCT revenue for 2025-09-30 was $336.1K. Net income was -$1.3M. PVCT currently screens at market cap $25.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PVCT stock page; for the tape open the quote page.
Not investment advice.